Female (69); Male (60)

0 to 4 years (6); 5 to 9 years (4); 10 to 14 years (8); 15 to 19 years (5); 20 to 24 years (22); 25 to 29 years (22); 30 to 34 years (32); 35 to 39 years (30)

Asian (5); Black or African American (3); Native Hawaiian or Other Pacific Islander (2); Other (4); White (81); Not Reported (1); Unknown (33)

Hispanic or Latino (17); Not Hispanic or Latino (70); Unknown (42)

Acute megakaryoblastic leukaemia (1); Acute monoblastic and monocytic leukemia (2); Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (3); Acute myeloid leukemia with maturation (1); Acute myeloid leukemia with mutated CEBPA (10); Acute myeloid leukemia with mutated NPM1 (17); Acute myeloid leukemia with myelodysplasia-related changes (7); Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 (4); Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1 (9); Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL (6); Acute myeloid leukemia without maturation (1); Acute myeloid leukemia, CBF-beta/MYH11 (18); Acute myeloid leukemia, minimal differentiation (2); Acute myeloid leukemia, NOS (21); Acute myelomonocytic leukemia (4); Acute promyelocytic leukaemia, PML-RAR-alpha (8); Mixed phenotype acute leukemia, B/myeloid, NOS (1); Mixed phenotype acute leukemia, T/myeloid, NOS (2); Myeloid leukemia associated with Down Syndrome (2); Myeloid sarcoma (2); Therapy related myeloid neoplasm (7); Undifferentiated leukaemia (1)

Bone Marrow (129)

RNA Sequencing (611); Whole Exome Sequencing (736)